T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: Peptide binding, immunodominance and effector functions of T cells

Journal of Neuroimmunology

Volumn 77, Issue 2, 1997, Pages 195-203

  Vergelli, M ^a   Kalbus, M ^b   Rojo, S C ^c   Hemmer, B ^a   Kalbacher, H ^d   Tranquill, L ^a   Beck, H ^d   McFarland, H F ^a   De Mars, R ^e   Long, E O ^c   Martin, R ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

HLA binding; HLA DR15; Immunodominance; MBP; Multiple sclerosis

Indexed keywords

ANTIGEN DR15; HLA ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ALLELES; AMINO ACID SEQUENCE; CATHEPSIN D; CELL LINE; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; HAPLOTYPES; HLA-DR ANTIGENS; HLA-DR2 ANTIGEN; HUMANS; HYDROLYSIS; IMMUNODOMINANT EPITOPES; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PEPTIDES; PROTEIN BINDING; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 18544397838     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00075-1     Document Type: Article

References (30)

1. Ceman, S., Rudersdorf, R.A., Petersen, J.M., DeMars, R., 1995. DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing. J. Immunol. 154, 2545-2551.
2. Deibler, G.E., Martenson, R.E., Kies, M.W., 1972. Large scale preparation of myelin basic protein from central nervous system tissue of several mammalian species. Prep. Biochem. 2, 139-165.
3. Fleury, S., Thibodeau, J., Croteau, G., Labrecque, N., Aronson, H.E., Cantin, C., Long, E.O., Sékaly, R.B., 1995. HLA-DR polymorphism affects the interaction with CD4. J. Exp. Med. 182, 733-741.
4. Fridkis-Hareli, M., Teitelbaum, D., Gurevich, E., Pecht, I., Brautbar, C., Kwott, O.J., Brenner, T., Arnon, R., Sela, M., 1994. Direct binding of myelin basic protein and synthetic copolymer I to class II major histocompatibility complex molecules on living antigen-presenting cells-specificity and promiscuity. Proc. Natl. Acad. Sci. USA 91, 4872-4876.
5. Gorga, J.C., Horejsi, V., Johnson, D.R., Raghupathy, R., Strominger, J.L., 1987. Purification and characterization of class II histocompatibility antigens from a homozygous human B cel line. J. Biol. Chem. 262, 16087-16094.
6. Jaraquemada, D., Marti, M., Long, E.O., 1990a. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J. Exp. Med. 172, 947-954.
7. Jaraquemada, D., Martin, R., Rosen-Bronson, S., Flerlage, M., McFarland, H.F., Long, E.G., 1990b. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J. Immunol. 145, 2880-2885.
8. Jaraquemada, D., Marti, M., Martin, R., Wagner, A., McFarland, H.F., Rosen-Bronson, S., 1994. Different requirements of ICAM-1/LFA-1 adhesion in allorecognition and self-restricted antigen recognition by class II-specific T cell clones. Eur. J. Immunol. 24, 947-952.
9. Kropshofer, H., Bohlinger, I., Max, H., Kalbacher, H., 1991. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets. Biochemistry 30, 9177-9188.
10. Kropshofer, H., Max, H., Halder, T., Kalbus, M., Muller, C.A., Kalbacher, H., 1993. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the N terminus including proline as a stop-signal for trimming. J. Immunol. 151, 4732-4741.
11. Lee, B.S.M., Rust, N.A., McMichael, A.J., McDevitt, H.O., 1987. HLA-DR subtypes form an additional supertypic family of DR beta alleles. Proc. Natl. Acad. Sci. USA 84, 4591-4595.
12. Long, E.O., Rosen-Bronson, S., Karp, D.R., Malnati, M., Sekaly, R.P., Jaraquemada, D., 1991. Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells. Hum. Immunol. 31, 229-234.
13. Martin, R., Jaraquemada, D., Flerlage, M., Richert, J., Whitaker, J., Long, E.O., McFarlin, D.E., McFarland, H.F., 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145, 540-548.
14. Martin, R., Howell, M.D., Jaraquemada, D., Flerlage, M., Richert, J., Brostoff, S., Long, E.O., McFarlin, D.E., McFarland, H.F., 1991. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173, 19-24.
15. Martin, R., McFarland, H.F., McFarlin, D.E., 1992a. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153-187.
16. Martin, R., Utz, U., Coligan, J.E., Richert, J.R., Flerlage, M., Robinson, E., Stone, R., Biddison, W.E., McFarlin, D.E., McFarland, H.F., 1992b. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148, 1359-1366.
17. Meinl, E., Weber, F., Drexler, K., Morelle, C., Ott, M., Saruhan-Direskeneli, G., Goebels, N., Ertl, B., Jechart, G., Giegerich, G., Schönbeck, S., Bannwarth, W., Wekerle, H., Hohlfeld, R., 1993. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple clones. J. Clin. Invest. 92, 2633-2643.
18. Ota, K., Matsui, M., Milford, E.L., Mackin, G.A., Weiner, H.L., Hafler, D.A., 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346, 183-187.
19. Pette, M., Fujita, K., Kitze, B., Whitaker, J.N., Albert, E., Kappos, L., Wekerle, H., 1990a. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40, 1770-1776.
20. Pette, M., Fujita, K., Wilkinson, D., Altmann, D.M., Trowsdale, J., Giegerich, G., Hinkkanen, A., Epplen, J.T., Kappos, L., Wekerle, H., 1990b. Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87, 7968-7972.
21. Richert, J.R., Reuben-Burnside, C.A., Deibler, G.E., Kies, M.W., 1988. Peptide specificities of myelin basic protein-reactive human T-cell clones. Neurology 38, 739-742.
22. Richert, J.R., Robinson, E.D., Deibler, G.E., Martenson, R.E., Dragovic, L.J., Kies, M.W., 1989. Human cytotoxic T-cell recognition of a synthetic peptide of myelin basic protein. Ann. Neurol. 26, 342-346.
23. Tiwari, J.L., Terasaki, P.I., 1985. HLA and Disease Associations. Springer-Verlag, New York, pp. 152-167.
24. Valli, A., Sette, A., Kappos, L., Oseroff, C., Sidney, J., Miescher, G., Hochberger, M., Albert, E.D., Adorini, L., 1993. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J. Clin. Invest. 91, 616-628.
25. Vergelli, M., Hemmer, B., Utz, U., Vogt, A., Kalbus, M., Tranquill, L., Conlon, P., Ling, N., Steinman, L., McFarland, H.F., Martin, R., 1996. Differential activation of human T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99). Eur. J. Immunol. 26, 2624-2634.
26. Vergelli, M., Pinet, V., Vogt, A.B., Kalbus, M., Malnati, M., Riccio, P., Long, E.O., Martin, R., 1997a. HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing. Eur. J. Immunol. 27, 941-951.
27. Vergelli, M., Hemmer, B., Muraro, P., Tranquill, L., Biddison, W.E., Sarin, A., McFarland, H.F., Martin, R., 1997b. Human autoreactive CD4+ T cell clones use perforin- or Fas ligand-mediated pathways for target cell lysis. J. Immunol. 158, 2756-2761.
28. Vogt, A.B., Kropshofer, H., Kalbacher, H., Kalbus, M., Rammensee, H.G., Coligan, J.E., Martin, R., 1994. Ligand motifs of HLA-DRB5*0101 and DRB1* 1501 molecules delineated from self-peptides. J. Immunol. 153, 1665-1673.
29. Whitaker, J.N., Seyer, J.M., 1979. The sequential limited degradation of bovine myelin basic protein from central nervous system tissue of several mammalian species. Prep. Biochem. 2, 6956-6962.
30. Wucherpfennig, K.W., Sette, A., Southwood, S., Oseroff, C., Matsui, M., Strominger, J.L., Hafler, D.A., 1994. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179, 279-290.